| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |